In summary, the present study demonstrated that the combination treatment of simvastatin and pinocembrin for 14 weeks significantly decreased serum lipid levels, improved endothelial function and reduced atherosclerosis in ApoE−/− mice, while the simvastatin had no prominent effect on serum cholesterol levels. This evidence concerns the gene APOE and atherosclerosis.